Zentalis Pharmaceuticals

About:

Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.

Website: https://www.zentalis.com

Twitter/X: ZentalisP

Top Investors: Pfizer, Perceptive Advisors, Redmile Group, Viking Global Investors, Surveyor Capital

Description:

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical business dedicated to finding and developing small molecule medicines that target cancer's underlying biological pathways. It employs an integrated discovery engine to find targets and produce small molecule new chemical entities, or NCEs, with features that it believes could result in potentially distinct product profiles. Its pipeline includes two lead product candidates: ZN-c5, which is being developed for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer, and ZN-c3, which is being developed for the treatment of advanced solid tumors as monotherapy and ovarian cancer.